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Acute renal injury
Acute renal failure (or acute kidney injury, AKI) is an
important issue in critical care because, as was demon-
strated in the past, the patients’ prognosis is dependent on
the disturbed renal function. In 2010, four interesting
reviews were presented dealing with general, but also with
some specific issues of AKI in critically ill patients: One of
the utmost important topics in this context is the question if
and how AKI may be prevented in patients at risk for
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developing AKI. The working group within the European
Society of Intensive Care Medicine (ESICM) consented on
an expert opinion list of recommendations [1]. This work
was based on a systematic literature search between 1966
and 2009. Several clinical conditions were elucidated, and
optional endpoints were extracted. The studies were graded
according to existing guidelines. The most important rec-
ommendations are prompt resuscitation of the circulation,
the use of vasoactive drugs under strict haemodynamic
monitoring and additional measures such as renal
replacement therapies (RRT). The problem of hypoalbu-
minemia and its relation to AKI was part of a special paper
presenting a meta-analysis of observational studies [2]. As
a result of the lack of clear evidence in this context, the
authors provide data from observational studies, with evi-
dence that hypoalbuminemia is a significant independent
risk factor both for AKI and for death following AKI
development. They conclude that any recommendations
regarding optional replacement of human albumin under
these conditions are premature, and controlled studies are
warranted to assess interventions aimed at correcting
hypoalbuminemia. The outcome after AKI in patients with
severe burns is the topic of another meta-analysis [3]. The
authors describe the prevalence and outcome of this spe-
cific patient group, with a three- to six-fold higher mortality
for AKI patients. In conclusion, this review clearly shows
that AKI remains prevalent and is associated with
increased mortality in patients with severe burn injury.
Finally, another group of authors discussed the age-related
changes, and examined the most frequent aetiologies for
renal impairment in the elderly [4]. They conclude that this
clinical entity will likely become more common, because
of the aging of the population, especially highlighting the
methods for prevention of AKI development or worsening
in the elderly critically ill patient.
Biomarker research in AKI has gathered enormous
momentum lately. New biomarkers are sought to aid the
earlier diagnosis of AKI as well predicting outcome
including requirement for RRT. A new biomarker, serum
angiopoietin-2, already shown to be associated with
increased mortality in sepsis, was also found to predict
28-day survival in a study including 117 critically ill
patients requiring RRT [5]. During recent years neutrophil
gelatinase-associated lipocalin (NGAL) has emerged as a
very promising early marker of AKI. Serum NGAL was
evaluated recently in more than 300 patients showing the
capability to predict AKI at least 24 h earlier than the risk,
injury, failure, loss, and end-stage kidney (RIFLE) criteria
in a mixed intensive care unit (ICU) population [6].
However, as already shown in children, NGAL released
from neutrophils is significantly elevated in sepsis even in
the absence of AKI. In line with these findings Bagshaw [7]
showed significantly higher serum NGAL values in
patients suffering from sepsis-associated AKI as compared
with non-septic AKI. Furthermore, Martensson et al. [8], in
a smaller study including only patients with sepsis, showed
that serum NGAL was not reliable in predicting AKI in this
specific patient group. Urinary NGAL, however, still
appeared promising in this setting showing an increase
between 12 and 24 h prior to detection of AKI by RIFLE.
In the face of these studies an accompanying editorial [9]
outlined that no single biomarker has yet reached the
required specificity to be regarded as the ‘‘renal troponin’’.
An increasing number of studies indicate that sepsis-
associated AKI must be considered an entity of its own.
Important insight into renal histopathologic changes was
provided by post-mortem autopsies in 19 patients who had
died from septic shock [10], which is currently the largest
investigation in this field. The authors found specific chan-
ges, namely capillary leukocyte infiltration in glomeruli and
capillaries as well as tubular cell apoptosis. These findings
are distinctly different from the so-called acute tubular
necrosis very frequently observed in AKI. Vasopressors are
an important tool in preventing deterioration of renal func-
tion in septic shock. Earlier studies indicated that the choice
of vasopressor is not that important [11]. On the contrary, a
secondary analysis of the vasopressin and septic shock trial
(VASST) showed that in the early stage RIFLE risk, vaso-
pressin was more effective than norepinephrine in
preventing progression to higher stages of RIFLE and even
requirement for RRT [12]. Though still requiring a ran-
domized controlled trial for validation these findings may
change recommendations for preventing AKI [1].
Increased body mass index (BMI) was found to be a risk
factor for developing AKI in the ICU [13]. This is in line with
previous studies indicating increased risk of morbidity in
obese critically ill patients [14]. Similar to this study obese
patients with a BMI between 30 and 35 were found to exhibit
the lowest mortality, substantiating the idea of modestly
increased BMI constituting a survival factor for ICU patients
and even influencing post ICU ward mortality.
Citrate anticoagulation has emerged as the preferred
method of anticoagulation during the last few years [15]
probably even being associated with superior survival [16].
Severe liver insufficiency as can be found in septic shock with
multiple organ failure has often been reported to be a limita-
tion for using citrate because of the danger of citrate
accumulation due to impaired metabolism. Excellent tolera-
bility of citrate anticoagulation has now been demonstrated in
a study including 70 burn septic shock patients treated with
continuous veno-venous haemodiafiltration (CVVHDF) [17].
The study showed excellent tolerability and higher efficacy
for citrate in terms of circuit survival as compared with hep-
arin anticoagulation in this very special group of patients.
Outcome and scores, ICU performance and risk
assessment
Refusal of admission to patients is a serious decision with
implications to patient survival. A multicentre, multinational
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study investigated factors influencing triage decision [18].
Factors like availability of ventilator beds, severity of dis-
ease, Karnofsky score, absence of comorbidities, presence of
haematological malignancies but not lower age per se posi-
tively influenced the probability of being admitted to an ICU.
Interestingly surgical and trauma patients were more likely
to be admitted than medical patients. As expected ICU
admission increased survival substantially in patients with
greater severity of disease.
Ward mortality after discharge is a nearly as impor-
tant issue. It is well known that admission scores are
very not suitable to predict mortality after discharge. The
Sabadell score is a subjective score categorizing dis-
charged patients into four groups based on physicians
evaluation of the patients ranging from ‘‘expected good
prognosis in the long term’’ (score 0) to ‘‘not expected to
survive hospital stay’’ (score 3) [19]. This score was
validated in a prospective multicentre trial in Spain
showing very reliable prediction of hospital survival at
ICU discharge [20].
The SAPS 3 project, which was endorsed by the
ESICM and carried out by 299 ICUs worldwide, was
aimed at providing a new model for improved risk
adjustment in critically ill patients which is accessible
cost-free to intensivists [21]. This score, already validated
repeatedly, exhibits superior performance to previous
severity scores. A large prospective cohort study under-
taken in Thailand analysing more than 1,800 patients
found excellent discrimination but poor calibration of
SAPS 3 in a medical intensive care patient requiring first-
level customization. A similar process has been required
with other severity scores when adapting to local popu-
lations. Analysing the data of 28 Brazilian ICUs a
customized equation of SAPS 3 for South American
countries was found to be very accurate in predicting
outcomes in critically ill cancer patients when compared
with other scores like SAPS II, Mortality Probability
Models III and Cancer Mortality Model [22]. Another
investigation from Norway demonstrated satisfying inter-
rater reliability for both SAPS 3 and SAPS II scores.
Standardized mortality ratio, however, showed larger
variability in SAPS 3. This finding is presumably due the
heavier reliance of SAPS 3 on data coming from inter-
pretation of charts, whereas SAPS 2 is more dependent on
laboratory values [23].
Two studies were concerned with organisation of
ICUs. The ICUFUND survey investigated reimbursement
practices [24] and demonstrated that ICU physicians
definitely prefer separate funding from hospitals and that
funding systems including nurse workload were consid-
ered superior. Obviously this parameter best reflects
actual use of resources by patients. In addition to financial
aspects, benchmarking is a very important issue, which
still is far from being optimal (e.g. when using average
standardized mortality ratio (SMR)). Moreno and
co-workers [25] published a brilliant approach to
characterize risk profiles for single ICUs. Instead of using
a single average SMR the authors established an indi-
vidualized profile by calculating deviation from an SMR
of 1 based on SAPS II for each severity class (i.e. SAPS II
score). This method provides a profile which depicts ICU
performance for patients at each degree of severity of
disease.
Implementing new therapeutic strategies in a complex
environment such as an ICU is not that simple, especially
when several categories of healthcare professionals are
involved. For instance, glucose control is a procedure that
requires a step-by-step implementation based on guide-
lines compatible with the local environment. Eslami et al.
[26] compared various aspects of glucose control (effi-
ciency/effectiveness, safety and protocol-related
indicators) in three different Dutch ICUs which used
different strategies for the implementation of glucose
control. A common hallmark was an increased rate of
hypoglycaemic events, but this did not stop the process of
guideline implementation. The effectiveness of glucose
control was variable, leading to substantial revision of
each of the guidelines. The use of computer-based
intensive insulin protocol is one of the future develop-
ments to improve the performance of glucose control.
Campion et al. [27] reported their 38-month experience in
two different ICUs and found that the manual transcrip-
tion of blood glucose values was a significant source of
error, resulting in inappropriate recommendations for the
insulin infusion rate.
Clinical-decision support systems were used success-
fully to decrease the risk of drug–drug interactions, as
shown by the comparison of a period where senior cli-
nicians were helped by a dedicated computerised
algorithm with usual care [28]. Patient safety was
improved, as shown by a decrease in the incidence of QT
interval prolongation and the incidence of hypokalaemia
when the computer-based algorithm efficiently decreased
the incidence of drug–drug interactions. In terms of safety
and adequacy of management, the outcomes of patients
with severe sepsis were compared according to the size of
ICU [29]. The major finding of this Finnish study was a
decreased mortality of surgical patients when they were
managed in a large ICU, as compared with smaller units.
In respect to safety, Bryland et al. [30] drew the attention
towards the presence of harmful glucose degradation
products in infusion fluids containing glucose, commonly
used during surgery and in ICUs. Importantly, these
glucose degradation products were also found in the
serum of patients as well as signs of advanced end gly-
cation products and attributable impairments of neutrophil
function.
Regarding risk stratification, Hausfater et al. [31]
reported the risk factors for mortality from the analysis of
a large database of hyperthermic patients admitted in an
emergency department in Paris during the 2003 heatwave.
Nine independent predictive factors for mortality were
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identified, allowing the development of a risk score and
the definition of three categories of risk.
The consequences of dysnatraemia (hyper- or hypo-)
present at ICU admission were carefully screened in a
national Austrian registry of more than 150,000 patients
[32]. Mild or severe dysnatraemia was found in 25% of the
admissions, and associated with increased raw and risk-
adjusted mortality ratio. The multiple logistic regression
analysis showed indeed an independent mortality risk rising
with increasing severity of hypo- and hypernatraemia.
The acquisition of paresis during an ICU stay is
another frequent complication, which is still incompletely
understood. In order to assess the influence of hormonal
factors, Sharshar et al. [33] prospectively measured the
plasma levels of pituitary and peripheral hormones in
patients at risk of ICU-acquired paresis. In those patients
with paresis, blood glucose concentration was increased
and the hormonal pattern of hypogonadism was found in
men.
Sepsis, mediators, genetic predisposition to sepsis
A multifaceted intervention promoted by the Surviving
Sepsis Campaign (SSC) [34] study group to facilitate
compliance with selected guideline recommendations for
management of severe sepsis and septic shock in the ICU,
emergency department (ED), and wards of individual
hospitals and regional hospital networks was imple-
mented voluntarily in the US, Europe and South America.
Elements of the guidelines were ‘‘bundled’’ into two sets
of targets to be completed within 6 h and within 24 h. An
analysis was conducted on data submitted from January
2005 through March 2008.
Analysing data on the compliance with bundle targets
and association with hospital mortality from 15,022 sub-
jects at 165 sites the authors showed that the reduction in
hospital mortality rates was associated with sustained,
continuous quality improvement in sepsis care. Compli-
ance with the entire resuscitation bundle increased
linearly from 10.9% in the first site quarter to 31.3% by
the end of 2 years (P \ 0.0001). Compliance with the
entire management bundle started at 18.4% in the first
quarter and increased to 36.1% by the end of 2 years
(P = 0.008). Compliance with all bundle elements
increased significantly, except for inspiratory plateau
pressure, which was high at baseline. Unadjusted hospital
mortality decreased from 37 to 30.8% over 2 years
(P = 0.001). The adjusted odds ratio for mortality
improved the longer a site was in the campaign, resulting
in an adjusted absolute drop of 0.8% per quarter and 5.4%
over 2 years (95% CI, 2.5–8.4%).
Novel important findings in the areas of pathogenesis
and biomarkers of sepsis were published in 2010 in
Intensive Care Medicine.
Accurate and reliable biomarkers are still needed to
aid an early diagnosis and monitoring of patients with
sepsis. New approaches derived from a better under-
standing of some of the complex mechanisms of the
septic response have been recently assessed. For instance,
pentraxin-3 (PTX3) is a newly discovered inflammatory
mediator produced by neutrophils, macrophages, myeloid
dendritic and endothelial cells. Mauri et al. [35] evaluated
the predictive value of PTX3 levels in a set of data from
90 patients with severe sepsis or septic shock. The main
finding was that persisting high levels of PTX3 were
associated with mortality, and with the severity of sepsis,
including the magnitude of coagulation and fibrinolysis
dysfunction.
Similarly, the release of soluble ST2, a negative reg-
ulator of the Toll-like receptors (TLR), can be assessed by
plasma concentration of soluble ST2 receptor (sST2).
Hoogerwerf et al. [36] indeed found that in a sample of 95
patients with severe sepsis admission values, persisting
high levels of sST2 correlated with disease severity and
mortality.
Inhibition of macrophage inhibitory factor (MIF), a
thioredoxin-like protein, is a potential novel therapeutic
strategy for sepsis. Connections between thioredoxin
itself and MIF were confirmed by Leaver et al. [37] who
found a significant correlation between the plasma levels
of thioredoxin and MIF in patients with sepsis/systemic
inflammatory response syndrome (SIRS). This finding
obviously opens the way to further research to confirm
this link and to understand its underlying mechanism.
Another intriguing aspect of the pathogenesis of sepsis
is the activation of the haeme oxygenase-1 (HO-1)
enzyme in monocytes, and the anti-inflammatory and
anti-oxidant of this pathway. Takaki et al. [38] confirmed
in septic patients a close correlation between the level
of expression of HO-1, the activity of the enzyme and
markers of oxidative stress.
Other novel insights into the field of the cytokine-
related pathways were also described. Single-nucleotide
polymorphisms of nine cytokine genes (out of 13) were
associated with ex vivo cytokine production by LPS-
stimulated leukocytes or risk of development of sepsis in
a cohort of trauma patients [39]. A relationship between
IL-6, IL-10 and the responsiveness to an ACTH stimu-
lation test were also reported by Kwon et al. [40], strongly
confirming an interference between the inflammatory
response and the neuro-endocrine pathway.
Another insight was described by Levy et al. [41] who
demonstrated an increased muscular lactate concentra-
tion, with a consistent muscle-to-serum lactate gradient,
in patients with severe sepsis. The muscular lactate was
also correlated with plasma epinephrine concentration,
suggesting a link with the activation of the Na?K?-
ATPase muscular enzyme.
Once again, these findings stress the increasing com-
plexity of the septic response and the involvement of
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several pathways. These recent data will likely lead to the
availability of more reliable biomarkers of sepsis and to a
better understanding of the susceptibility to infection and
the variability in the severity of sepsis.
There are many approaches to understand the patho-
physiology of systemic infections and severe sepsis, one
of which was the topic of a sound review of the RAGE
axis, which stands for ‘‘receptor for advanced glycation
end-products’’ and its ligands [42]. The RAGE-dependent
mechanisms have been identified for a wide range of
disorders such as systemic inflammation, acute lung
injury and myocardial dysfunction. The numerous animal
experiments are presented showing the beneficial effects
of inhibiting these mechanisms. The authors conclude that
also in humans, the potential for using these pathways for
evaluating novel therapeutic approaches does exist. Other
pathways such as TLR-dependent mechanisms were pre-
sented in another review [43], elucidating the role in
bacterial infection and sepsis, but also for non-septic
inflammatory response. The authors give insight into
pathophysiology of TLR-2 and -4 contributing to organ
dysfunction and critical illness. In addition, optional
therapeutic consequences are part of this overview. A
similar issue was covered in a paper on soluble mediators
causing ventilator-induced lung injury and multi-organ
failure [44]. Cytokines, coagulation factors, hormones,
lipid-derived mediators, and oxidants are described based
on a broad literature search, thus covering the roles of
these mediators in the pathophysiology, and trying to
describe ‘‘candidate mediators’’.
A decreased level of mitochondial DNA (mtDNA) has
been reported in blood from septic patients. Pyle et al.
[45] collected blood from 147 patients with severe sepsis
and in 83 healthy control subjects. They confirmed a
marked diminution of mtDNA in septic patients compared
with healthy controls. In a subgroup of 13 patients, they
showed that this apparent decrease was due to an increase
of circulating neutrophils (containing less mtDNA com-
pared with other leukocyte types). However, septic
monocytes also had a decreased mtDNA content and
correlated with disease severity (APACHE II score).
Several papers published in Intensive Care Medicine
in 2010 concentrated on the central role of microcircu-
latory failure in organ dysfunction and sepsis. The
physiological functions of the vascular endothelium were
described as a highly dynamic cell layer controlling
coagulation state, permeability, growth state and vascular
tone [46]. Most of these functions have been discovered
as key mechanisms involved in pathogenesis of micro-
circulatory failure in severe sepsis. The resulting
‘‘hyporesponsiveness’’, a major problem during vaso-
pressor therapy in septic shock, was the topic of another
review discussing basic physiology, but also providing
clinical data on the relation between vasoactive drugs and
organ perfusion [47]. In addition, a brief outline was
presented demonstrating current therapeutic strategies and
possible future approaches. As a logical consequence, this
leads to the striking role of new techniques for better
diagnosis and monitoring of microcirculation, which was
described in another paper [48]. A sound review of the
current literature on methods used to evaluate the
microcirculation in humans is the major part of this
manuscript. The techniques currently available for the
clinician to assess patients with severe sepsis and septic
shock are discussed, with special regard to microvideo-
scopic techniques, as well as laser Doppler and near-
infrared spectroscopy techniques. Finally, the therapeutic
approaches for improvement of microcirculatory failure
were elucidated, with special attention paid to recent
developments that have enabled direct in vivo observation
of the microcirculation and concepts that have originated
from it [49]. A Medline search was conducted by ana-
lysing eighty original papers evaluating the specific
relationship between perfusion and vasoactive drugs,
demonstrating a wide range in interindividual effects.
Neuro intensive care
Non-invasive monitoring: NIRS, TCD and BIS
Three mainstays of the medical treatment of patients with
traumatic brain injury (TBI) are to control raised intra-
cranial pressure (ICP) and to maintain cerebral perfusion
pressure (CPP) and cerebral oxygenation within normal
ranges. Consequently, monitoring of these parameters in
neurocritical care is important; however, it requires
invasive systems. A more ideal approach would be non-
invasive measurements of cerebral oxygenation. In this
regard, near-infrared spectroscopy (NIRS) offers hope
[50]. Basically, in NIRS, light generated at specific
wavelengths is transmitted through the scalp into the
brain, and changes in the light attenuation at the receiving
end are converted via a computer algorithm into changes
in chromophore concentration. NIRS captures an average
of the arterial, capillary and venous compartments.
Translation of NIRS systems and methods into the clinical
field requires an understanding of the physiologic basis of
the measured NIRS signals, and unfortunately some
uncertainly still remains. Leal-Noval [51] compared in a
prospective, observational study in 22 stable patients with
severe traumatic brain injury (TBI) the relationship
between the standard invasive brain tissue oxygen pres-
sure (PbrO2), measured with a Licox system, and non-
invasive regional transcranial oxygen saturation (rSO2).
PbrO2 is the partial pressure of oxygen in the extra-
cellular fluid of the brain and reflects the availability of
oxygen for oxidative energy production. It represents the
balance between oxygen delivery and consumption, and is
influenced by changes in capillary perfusion. PbrO2
measurement contributes to the prevention of delayed
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cerebral damage after TBI and other acute neurological
conditions. Normal PbrO2 values based on Licox tech-
nology are around 25–30 mmHg, based on animal
research. This was confirmed in patients with normal ICP
and CPP. The likelihood of death increased with
increasing duration of time at or below a PbrO2 of
15 mmHg. The continuous monitoring of PbrO2 is now
accepted as being safe and feasible. Initial concerns
regarding the invasiveness of these intraparenchymal
sensors and the risk of haemorrhage and infection have
proved negligible. Nevertheless the possibility of obtain-
ing comparable information with non-invasive, less
expensive, economically and biologically, systems
remains attractive.
Leal-Noval [51] monitored each patient during a 16-h
period allowing a total of 41,809 paired records variables
to be analysed and compared. Although a relationship
between rSO2 and PbrO2 was confirmed, the authors
reported low accuracy for detecting episodes of moderate
cerebral hypoxia, defined as a PbrO2 B 15 mmHg.
Higher sensitivity and specificity was found at a lower
cutoff value, i.e. PbrO2 B 12 mmHg, representing more
severe cerebral hypoxia.
These observations cast further doubts on the potential
applicability of NIRS in TBI. Whether NIRS has added
value or even any value in TBI cannot be directly
answered on the basis of this study. Of concern is that
45% of the original sample size of 56 patients were
excluded for reasons specific to TBI or the technology:
frontal haematoma, wounds on either the scalp or fore-
head, or deficient NIRS signal. Subcutaneous swelling or
wounds on scalp and forehead are common in TBI
patients. Intracranial lesions and/or recent surgery would
further prohibit use of the technique. Uncertainty also
exists regarding how traumatic subarachnoid haemor-
rhage may confound the signal. A technique that, in TBI,
may not be applicable in nearly half of patients would
seem of limited value. These factors, specific to TBI, set
this disease aside with regard to the applicability of NIRS
from other more controlled conditions such as extracra-
nial vascular surgery. The study by Leal-Noval
strengthens the opinion that NIRS technology may have
potential but is not yet ready for routine clinical use in
TBI.
Two studies explored application of an another fre-
quently used non-invasive method, transcranial Doppler
(TCD), in evaluating autoregulatory status in intracerebral
haemorrhage (ICH) [52] and in detecting traumatic car-
otid dissection [53].
TCD ultrasonography is a non-invasive technique that
allows one to observe velocity, direction and properties of
blood flow in the cerebral arteries by means of a pulsed
ultrasonic beam. TCD can be used to evaluate the state of
cerebral autoregulation, or the ability of the cerebral
vascular bed to undergo constriction or dilatation in
response to various modifications of the cerebral
perfusion pressure (CPP), to keep the cerebral blood flow
(CBF) constant. The test essentially consists of assessing
the changes of the flow velocity in mean cerebral artery
(MCA) during changes in CPP, given that changes in
MCA velocity reliably correlate with changes in cerebral
blood flow.
ICH is a medical emergency, and delays in treatment
result in worse outcome. Initial management should focus
on urgent stabilization of cardiorespiratory variables and
treatment of intracranial complications. Blood pressure
management in ICH intracerebral haemorrhage is a cor-
nerstone of the medical treatment and relies on
functioning cerebral autoregulation. The association of
high blood pressure (BP) and haematoma expansion is
controversial. High blood pressure in patients with ICH
may cause increased bleeding and haematoma growth.
Several guidelines on ICH management advocate appro-
priate blood pressure control. Nevertheless, targets for
treatment remain controversial.
The risks of a sudden therapeutic reduction in BP after
ischaemic stroke are well known and are more evident in
patients with disrupted autoregulation.
Reinhard [52] evaluated the time course of autoregu-
lation in 26 patients with spontaneous ICH, studied on
days 1, 3 and 5 after cerebral ictus. Autoregulation was
non-invasively measured from spontaneous fluctuations
of blood pressure and middle cerebral artery flow veloc-
ity, assessed by transcranial Doppler, using the correlation
coefficient index Mx [54]. Mean values of ABP and
CBFV were averaged over 3 s. From every 20 such seg-
ments (i.e. 60-s periods) separate Pearson’s correlation
coefficients between ABP and CBFV were calculated.
The resulting 1-min correlation coefficients were then
averaged to form the autoregulatory index Mx. This index
was calculated for MCA sides ipsilateral and contralateral
to the ICH. From the same signals, non-invasive cerebral
perfusion pressure was calculated. Results were compared
with 55 healthy controls and related with clinical and
radiological factors and 3-month outcome utilizing the
modified Rankin scale. Average Mx values of all patients
did not differ across days or from controls. Higher Mx,
i.e. poorer autoregulation, on day 5 was significantly
related with more severe cases: lower Glasgow coma
score (GCS), ventricular haemorrhage and lower non-
invasive cerebral perfusion pressure. Increasing ipsilateral
Mx between days 3 and 5 was related with lower Glasgow
coma score and ventricular haemorrhage. In a multivari-
ate analysis controlling for other haemodynamic factors,
higher ipsilateral Mx on day 5 (P = 0.013) was a sig-
nificant predictor for poor 90-day outcome.
Therefore, cerebral autoregulation is primarily pre-
served in acute ICH, but a secondary decline, mainly
ipsilateral, to the ICH can occur in more severe cases.
Cerebral autoregulation still provokes debate, partic-
ularly in the context of clinical management of
neurocritical care patients. This study by Reinhard [52]
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demonstrated that autoregulation could be tested routinely
and that it could be disturbed in more severe cases.
The missing link we have to explore in the future is if the
evaluation of autoregulatory status could be helpful in
selecting a more adequate pressure range during the ICU
stay. We are still not able to respond to this crucial question.
Another application of TCD has been explored by
Bouzat [53], i.e. the detection of traumatic internal carotid
artery dissection using transcranial Doppler in head-
injured patients. Traumatic dissections of cervical arteries
are a rare injury. This complication is frequently missed
after multiple injuries or minor neck trauma. Early diag-
nosis of traumatic internal carotid artery dissection
(TICAD) is essential for initiating appropriate treatment
that encompasses blood pressure control, avoiding hypo-
and hypertension, and early, i.e. before the appearance of
cerebral ischaemic symptoms, anticoagulant treatment.
Early appropriate treatment could improve outcome in
TICAD.
Bouzat searched for criteria, from TCD measurements
on admission, that could be associated with subsequent TI-
CAD diagnosis in a retrospective cohort study of 11 TBI
patients with TICAD and absent or mild brain lesions on
initial CT scan, 22 TBI controls with comparable brain CT
scan lesions (controls 1), and 22 TBI controls with more
severe brain CT scan lesions (controls 2) on admission.
TCD measurements were obtained on admission from
both MCA. All patients had subsequent CT angiography
to diagnose TICAD. A greater than 25% asymmetry in the
systolic blood flow velocity between the two MCA was
found in 9/11 patients with TICAD versus 0/22 in controls
1 and 5/22 in controls 2 (P \ 0.01). The combination of
this asymmetry with an ipsilateral pulsatility
index B 0.80 was found in 9/11 patients with TICAD
versus none in the two groups of controls (P \ 0.01).
These results suggest that significant asymmetry in the
systolic blood flow velocity between the MCAs and a
reduced ipsilateral pulsatility index could be criteria from
TCD measurements associated with the occurrence of
TICAD in head-injured patients. To be universally
accepted and incorporated in screening protocols for TI-
CAD in TBI patients these results, even if encouraging,
need to be prospectively validated. If a suspicion of post-
traumatic TICAD is present, this non-invasive method
could help in the selection of patients to study with a CT
angiography (CTA). CTA has an established role in the
diagnosis of internal carotid artery dissection, and the
increased use and availability of high-resolution multi-
detector scanners has fast replaced angiography and
possibly MRA as the diagnostic modality of choice.
Another non-invasive monitoring system, bispectral
index (BIS), has been tested in comatose survivors of
cardiac arrest (CA) treated with therapeutic hypothermia
(TH). TH improves outcome in comatose survivors of
cardiac arrest and is an accepted standard of treatment
nowadays. Unfortunately, TH also alters the predictive
value of the classical neurologic prognostication [55] in
patients with postanoxic coma and new paradigms have to
be identified.
The optimal approach to the prognostic evaluation of a
patient treated with targeted temperature management has
not been fully resolved. This is an issue of crucial
importance, because it is ethically justifiable to limit care
or withdraw support only when a poor prognosis is rea-
sonably certain. Monitoring with electroencephalography
(EEG) has been recommended and both human and animal
data suggest that EEG and somatosensory-evoked potentials
correlate with neurological outcomes if recorded after HT.
Recent reviews have identified the need for simpler EEG
technology that non-neurologists can routinely perform and
interpret. BIS is a processed EEG monitoring tool that
evaluates the electrical brain activity, ranging from zero,
equivalent to a fully suppressed isoelectric EEG, to 100 in the
awake patient. An accompanying variable, the suppression
ratio (SR), estimates the percentage of each 1-min epoch that
is isoelectric, also ranging from 0–100%.
On this track, Seder [56] evaluated the BIS and SR as
very early predictors of neurological outcome during
therapeutic hypothermia after CA in 97 patients after the
first dose of neuromuscular blockade. BIS1 and SR1 were
defined as the sustained plateau values in the 5–10 min
after the first dose of neuromuscular blockade by
observing the trend line from the BIS monitor. Outcomes
evaluation (cerebral performance category, CPC) at dis-
charge, was blinded. Good neurological outcome has been
defined as a CPC 1-2 (GO) and poor outcome as a CPC 3-
5 (PO). Receiver-operator characteristic curves and a
multiple logistic regression model were constructed for
GO and PO. The BIS1 was higher in patients with GO (37
[28–41] vs. 7 [3–15], P \ 0.001). BIS1 \ 22 predicted
PO with a likelihood ratio (LR) of 14.2 and an area under
the curve (AUC) of 0.91 (95% CI 0.85–0.98, P \ 0.001).
SR1 C 48 predicted PO with a LR of 12.7 and an AUC of
0.90 (95% CI 0.83–0.98, P \ 0.001). Both BIS1 (DAUC
0.16, P = 0.006) and SR1 (DAUC 0.16, P = 0.005)
predicted outcomes better than the time to return of
spontaneous circulation.
In this single-centre cohort utilizing moderate seda-
tion, bispectral index and suppression ratio recorded
immediately after the first dose of neuromuscular block-
ade were accurate and very early predictors of
neurological outcome during therapeutic hypothermia
after cardiac arrest. According to these data and other
research in the field, updated practical guidelines for
prediction of outcome in comatose survivors after car-
diopulmonary resuscitation are more than expected.
Delirium and sedation
Delirium is increasingly recognized as a major adverse
event occurring postoperatively in surgical patients. Once
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the diagnosis has been established, the main goal of
delirium therapy is to identify important, potentially life-
threatening, treatable, organic causes responsible for this
syndrome.
Nevertheless it is difficult to substantiate the clinical
diagnosis of postoperative delirium with objective
parameters in ICUs. The purpose of a study of the Hei-
delberg group [57] was to analyse whether BIS index,
cortisol and interleukin-6 were different in delirious
patients as compared with non-delirious ones after cardiac
surgery.
On the first postoperative day, delirium was analysed
in 114 patients by using the confusion assessment method
for ICU (CAM-ICU). Bilateral BIS data were determined.
Immediately thereafter plasma samples were drawn to
analyse patients’ blood characteristics. The current ICU
medication, haemodynamic characteristics, SOFA and
APACHE II scores, and artificial ventilation were noted.
Delirium was detected at 19.1 ± 4.8 h after the end of
surgery in 28% of the patients. Delirious patients were
significantly older than non-delirious ones and were
artificially ventilated 4.7-fold more often during the
testing. Interestingly, in delirious patients, plasma cortisol
and interleukin-6 levels were higher (P = 0.01). The
mean BIS index was significantly lower in delirious
patients (72.6 (69.6–89.1); median [interquartile range
(IQR), 25th–75th percentiles] than in non-delirious
patients, 84.8 (76.8–89.9). BIS EEG raw data analysis
detected significant lower relative alpha and higher theta
power. A significant correlation was found between
plasma cortisol levels and BIS index. The authors dem-
onstrated that early postoperative delirium after cardiac
surgery was characterized by increased stress levels and
inflammatory reaction. BIS index measurements showed
lower cortical activity in delirious patients with a low
sensitivity (27%) and high specificity (96%).
Anxiolytics are often required in ICU for sedative
comfort and patient safety. Yet sedative regimens typi-
cally incur consequences of reduced consciousness,
impaired cognition and the risk of delirium. Recent
emphasis has been towards reducing the depth of seda-
tion, which has been instrumental in reducing mortality
and overall ICU length of stay. Such principles are
introduced in guidelines for ‘‘cooperative’’ patient seda-
tion [58]. Additional benefits of a more awake patient
include conservation of patient autonomy and early rec-
ognition of evolving neurological deterioration.
Commonly used ICU sedatives such as potent narcotics
and benzodiazepines have been demonstrated to incite
cognitive dysfunction and delirium. Dexmedetomidine
(DEX) is an alpha2-agonist that appears to offer sedation
without alteration in level of arousal or incurring a high
incidence of delirium. Mirski [59] hypothesized that opti-
mal titration of this agent may also have modest impact on
cognitive function. At the Johns Hopkins, Mirski con-
ducted a prospective, randomized, double-blinded study
comparing DEX and propofol (PRO), a sedative-hypnotic
often used for continuous ICU sedation, using an
ICU-validated cognitive assessment tool, i.e. the validated
100-point Hopkins ACE adapted cognitive exam (ACE)
cognitive battery. The aim of the study was to evaluate
which sedative regimen offered the least decrement in
intellectual capacity on awake and intubated brain-injured
(BI, n = 18) and non-BI (12) ICU patients. Each patient
received fentanyl/PRO and fentanyl/DEX titrated to a
calm, awake state using a crossover design. Cognitive
testing was performed at each study period using the ACE
cognitive battery.
Sedation with PRO diminished adjusted ACE scores
by a mean of -12.4 (95% CI -8.3 to -16.5, P \ 0.001),
whereas DEX improved ACE scores (6.8, 95% CI
1.2–12.4, P \ 0.018). The difference in the change of
ACE score between DEX versus PRO, the primary end-
point, was 19.2 (95% CI 12.3–26.1 P \ 0.001) in favour
of an improved ACE score on DEX. Patients with BI
required less sedative, but effects of PRO and DEX on
cognition were not changed. No serious adverse events
occurred. Modest bradycardia was noted post hoc with
DEX (-7.7 bpm, P \ 0.01).
ICU patients may be offered sedation without neces-
sarily compromising arousal or cognition. DEX seems a
promising drug for obtaining this aim. Alleviation of
anxiety and agitation can singly and effectively improve
mental engagement and performance if overt forebrain
dysfunction is avoided. Higher ACE scores with DEX
may be a consequence of the intellect-sparing yet calming
effect of this drug.
CNS complications in ICU
Admission of patients with malignancies to ICUs remains
a very controversial issue. Neurological complications are
common life-threatening events in patients with malig-
nancies. Central nervous system (CNS) involvement
requiring admission to the ICU has been reported in up to
20% of critically ill patients with malignancies. However,
there are no studies specifically designed to determine the
causes and outcomes of neurological events in this pop-
ulation. The information on CNS involvement in critically
ill patients with cancer are scanty. Legriel [60] conducted
a retrospective study of 100 consecutive critically ill
cancer patients admitted to an ICU with central neuro-
logical events over a 7-year period. The study objective
was to obtain information on the nature and outcomes of
neurological events in critically ill cancer patients hos-
pitalized in the ICU. These patients were managed by
using standardized diagnostic and therapeutic strategies.
Presenting manifestations were coma (56%), epilepsy
(48%), focal signs (35%), encephalopathy (31%) and
meningitis (7%). Cerebral imaging was abnormal in 61
patients, lumbar puncture in 17 and electroencephalography
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in 6. Neurosurgical biopsy was performed on four
patients. The main aetiologies included drug toxicity in
28, malignant brain infiltration in 21 patients and cere-
brovascular disease in 20. Mechanical ventilation was
needed for 60 patients. Anticancer chemotherapy was
administered during the ICU stay in 15 patients. ICU and
hospital mortalities were 28 and 45%, respectively. By
multivariate analysis, independent positive predictors of
hospital mortality were poor performance status [odds
ratio (OR) 2.94, 95% CI, 1.01–8.55, P = 0.047), focal
signs at presentation (OR 3.52, 95% CI, 1.14–10.88,
P = 0.029), abnormal lumbar puncture (OR 5.49, 95% CI
1.09–27.66, P = 0.038) and need for vasoactive drugs
(OR 6.47, 95% CI 1.32–31.66, P = 0.021). Remission of
the malignancy (OR 0.20, 95% CI 0.04–0.88, P = 0.033)
and GCS score at admission (OR 0.81/point, 95% CI,
0.70–0.95, P = 0.009) were negative predictors of hos-
pital mortality.
Central neurological events are mainly related to
malignant brain infiltration and drug-related toxicity.
Despite advanced severity, a standardized intensive
management strategy yields a 55% hospital survival rate.
As concluded in the accompanying editorial [61] these
data should encourage the intensivist to evaluate opening
the doors of the ICU to patients with malignancies and
neurological complications, enabling them to receive
optimal care.
Neuromuscular abnormalities are common in ICU
patients and can have an impact on patients’ ICU stay.
Brunello [62] evaluated the incidence of clinically diag-
nosed ICU-acquired paresis (ICUAP) and its impact on
outcome. Forty-two patients with SIRS on mechanical
ventilation for at least 48 h were prospectively studied.
Diagnosis of ICUAP was clinically defined as symmetric
limb muscle weakness in at least two muscle groups at
ICU discharge without other explanation. The threshold
Medical Research Council (MRC) score was set at 35 (of
50) points. Using this score, full muscle strength results in
5 points (M5) per tested muscle. A clinical diagnosis of
ICUAP was made when weakness (BM3) was diffuse,
bilateral, involving upper and lower extremities, and
resulted in a greater than 30% reduction in MRC score
(\35 points), independent of presence or absence of
sensitivity disturbance or reduced tendon reflexes.
Activities in daily living were scored by using the Barthel
index 28 and 180 days after ICU discharge. ICUAP was
diagnosed in 13 of the 39 patients (33%). Multivariate
regression analysis yielded five ICUAP-predicting vari-
ables (P \ 0.05): SAPS II at ICU admission, treatment
with steroids, muscle relaxants or norepinephrine, and
days with sepsis. Patients with ICUAP had lower admis-
sion SAPS II scores [37 ± 13 vs. 49 ± 15 (P = 0.018)],
lower Barthel index at 28 days and lower survival at
180 days after ICU discharge (38 vs. 77%, P = 0.033)
than patients without ICUAP. Daily TISS-28 scores were
similar but cumulative TISS-28 scores were higher in
patients with ICUAP (664 ± 275) than in patients with-
out ICUAP (417 ± 236; P = 0.008). The only
independent risk factor for death before day 180 was the
presence of ICUAP. A clinical diagnosis of ICUAP was
frequently established by Brunello in this patient group.
Despite lower SAPS II scores, these patients needed more
resources and had high mortality and prolonged recovery
periods after ICU discharge.
In order to better evaluate muscular weakness in ICU,
Fan [63] evaluated inter-rater reliability of manual muscle
strength testing in ICU survivors and simulated patients.
The goal of the paper was to determine inter-rater reli-
ability of trained examiners performing standardized
strength assessments using manual muscle testing
(MMT). The authors report on 19 trainees undergoing
quality assurance within a multi-site prospective cohort
study. Inter-rater reliability was evaluated for specially
trained evaluators (‘‘trainees’’) and a reference rater,
performing MMT using both simulated and actual
patients recovering from critical illness. Across 26 muscle
groups tested by 19 trainee–reference rater pairs, the
median (interquartile range) per cent agreement and
intraclass correlation coefficient (ICC; 95% CI) were 96%
(91, 98%) and 0.98 (0.95, 1.00), respectively. Across all
19 pairs, the ICC (95% CI) for the overall composite
MMT score was 0.99 (0.98–1.00). When limited to actual
patients, the ICC was 1.00 (95% CI 0.99–1.00). The
agreement (kappa; 95% CI) in detecting clinically sig-
nificant weakness was 0.88 (0.44–1.00). MMT has
excellent inter-rater reliability in trained examiners and is
a reliable method of comprehensively assessing muscle
strength.
Outcome prediction in SAH
Mortality due to aneurysmal subarachnoid haemorrhage
(aSAH) fell by about 50% over the last 2 decades, due
mainly to improved outcomes in cases surviving to reach
hospital, without a substantial increase in the proportion
of survivors with more severe disability [64]. The major
cause of poor outcome in aSAH patients is related to
neurologic injury caused by the haemorrhage itself and
the neurologic sequelae that follow. An accurate early
anticipation of long-term irreversible brain damage during
the acute phase of patients with aSAH remains difficult.
For exploring the possibility to develop a multipara-
metric prognostic panel to facilitate early outcome
prediction following aSAH, Turck [65] tested a combi-
nation of clinical scores together with brain injury-related
biomarkers (H-FABP, NDKA, UFD1 and S100beta).
Over the past few years, a large number of biomarkers,
present in the blood and CSF, have raised interest in the
detection of aSAH patients with poor clinical outcome.
Nevertheless, the majority of these markers displayed
either low sensitivity or specificity to anticipate the
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detection of patients with poor outcome. Turck et al. [66,
67] tested post-mortem CSF as a model of massive brain
insult. In these studies, heart-fatty acid binding protein
(H-FABP), nucleotide diphosphate kinase A (NDKA) and
ubiquitin fusion degradation protein 1 (UFD-1) were
over-expressed in post-mortem compared to ante-mortem
CSF and were validated as potential brain damaged bio-
markers. Turck et al. [65] hypothesized that such a
plasmatic marker may provide quantitative information
reflecting the prediction of aSAH patient outcome. At
hospital admission, S100b, H-FABP, troponin I, NDKA
and UFD-1 protein blood concentrations were determined
in patients with spontaneous aSAH. In addition to specific
clinical parameters, their potential predictive power to
detect poor 6-month outcome following aSAH evacuation
was also tested.
Blood samples of 141 aSAH patients from two sepa-
rated cohorts (sets of 28 and 113 patients) were
prospectively enrolled and analysed with 14 months of
delay. Patients were admitted within 48 h following aSAH
onset. A venous blood sample was withdrawn within 12 h
after admission. H-FABP, NDKA, UFD-1, S100beta and
troponin I levels were determined by using classical
immunoassays. The World Federation of Neurological
Surgeons (WFNS) score at admission and the Glasgow
outcome score (GOS) at 6 months were evaluated.
In the two cohorts, blood concentration of H-FABP,
S100beta and troponin I at admission significantly pre-
dicted unfavourable outcome (GOS 1-2-3). A multivariate
analysis identified a six-parameter panel, including
WFNS, H-FABP, S100beta, troponin I, NDKA and UFD-
1; when at least three of these parameters were simulta-
neously above cutoff values, prediction of unfavourable
outcome reached around 70% sensitivity in both cohorts
for 100% specificity.
The use of this panel, including four brain injury-
related proteins, one cardiac marker and a clinical score,
could be a valuable tool to identify aSAH patients at risk
of poor outcome. Although the results of the present study
are encouraging, additional studies are needed to establish
the validity of this approach.
Experimentals
Mechanical ventilation, biomarkers of acute lung
injury, and ischaemia reperfusion
A number of excellent studies published in 2009–2010
examined the mechanisms of ventilator-induced lung
injury (VILI) and investigated the effects of different
ventilatory strategies and pharmacological interventions
in protecting the lung from VILI.
VILI is associated with biotrauma involving inflam-
matory cascade activation. An elegant study by Fanelli
et al. [68] showed that pulmonary-derived phosphoinosi-
tide 3-kinase gamma (PI3 K) may play a central role
contributing to VILI. In an isolated and perfused lung
model, the investigators observed that PI3 K gene
knockout mice had better preserved lung structure com-
pared with wild-type mice in response to a given
mechanical stress. The lung in PI3 K knockout mice
showed a reduction in phosphorylation of protein kinase
B (Akt), endothelial nitric oxide synthase (eNOS), pro-
duction of nitrate and nitrotyrosine, and cAMP
hydrolysis. These findings were further confirmed by
using a PI3 K kinase inhibitor in combination with an
inhibitor of cAMP hydrolysis in wild-type mice, sug-
gesting PI3 K as a possible therapeutic target in the
context of VILI.
The acute respiratory distress syndrome (ARDS)
associated with transfusions, named transfusion-related
acute lung injury (TRALI), may be largely overlooked as
it often goes unrecognized. In particular, ARDS patients
may be at high risk to develop TRALI under treatment
with mechanical ventilation. This speculation is supported
by a recent study by Vlaar et al. [69]. The investigators
showed that within 2 h after administration of MHC-I
antibodies, mice ventilated with low tidal volume develop
TRALI which deteriorated with high tidal volume venti-
lation. In addition to biotrauma, it is suggested that
maldistribution of tidal volume may have led to VILI.
Thus an optimal PEEP level may be required to keep
better regional volume distribution. For this purpose,
electrical impedance tomography (EIT) was recently
tested to identify regional tidal volume and compliance.
In saline lavage-induced lung injury model in neonatal
piglet, Dargaville et al. [70] measured global and regional
tidal volume and compliance over a broad range of PEEP
levels. They demonstrated that a PEEP level can be
identified by EIT to achieve better distribution of regional
tidal volume after lung recruitment. This suggests that
EIT may be a useful tool to help select optimal PEEP in
keeping the lung open. Beside the dedicated technique,
researchers also search for simple techniques evaluating
pulmonary oxygenation or gas exchange. Rees et al. [71]
proposed a mathematical model to calculate oxygenation
data upon changing the inspired oxygen fraction. They
compared the results with those obtained using the mul-
tiple inert gas elimination technique as a reference to
describe inert gas data from heterogeneous lung damage.
They found that the simple mathematical model and the
multiple inert gas elimination technique are comparable
in simulating partial oxygen tension values, and the
comparability and accuracy were similar over different
ventilator settings. This observation may provide an
alternate approach to estimate gas exchange in certain
clinical situations.
From the therapeutic point of view, different patterns
of mechanical ventilation may have an important impact
on the outcome of lung injury. An interesting study by
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Saddy et al. [72] compared the effects of different assisted
ventilation modes in rats where initial lung injury was
induced by administration of paraquat. The investigators
reported that assisted ventilation modes led to better lung
function and less inflammation and injury as compared
with pressure-controlled ventilation. Henzler et al. [73]
further investigated the effects of spontaneous breathing
during mechanical ventilation on haemodynamics and
lung injury in a pig model of intra-abdominal hyperten-
sion. When the animals were ventilated with biphasic
positive airway pressure in the presence of unsynchro-
nized spontaneous breathing, no improvement in
haemodynamics but a greater degree of lung damage were
observed. These results alert one against the use unsup-
ported spontaneous breaths during mechanical ventilation
with biphasic positive airway pressure during severe
intra-abdominal hypertension.
Therapeutic interventions may have a place in reduc-
ing VILI. In a mouse model of VILI induced by high tidal
volume ventilation, Peltekova et al. [74] reported that
hypercapnia attenuated lung inflammation and injury in a
dose–response and time-dependent manner. In particular,
hypercapnia suppressed the expression of prostanoid-
generating enzyme (COX-2) at both gene and protein
levels. However, hypercapnia elevated the levels of ni-
trotyrosine in lung tissue, suggesting an increased
oxidative stress. The results confirm the potential bene-
ficial and detrimental effects of using hypercapnia. These
effects must be taken into account when the hypercapnia
approach is applied in the context of VILI. However, the
study did not address whether the permissive hypercapnia
is involved in hypermetabolism during mechanical stress.
Because mechanical ventilation is delivered on a 24-h
basis, inadequate adjustment leading to excessive work of
breathing may result in hypermetabolism. Aslami et al.
[75] tested the hypothesis that suspended animation is
protective in VILI by reducing metabolism. In mechani-
cally ventilated rats, VILI was induced by high pressure
ventilation in the presence and absence of sodium hy-
drosulfide (NaSH, H2S donor) infusion. The authors
reported that NaSH dose-dependently reduced body
temperature, heart rate, expired CO2, and pulmonary
inflammation. The anti-inflammatory effect was not
observed in animals subjected to hypothermiato to a
similar extent as seen with administration of H2S. This
study suggests that NaSH induces a hypometabolic state
and reduces pulmonary inflammation, which is indepen-
dent of body temperature. Further research is required to
confirm the findings and to understand the mechanisms by
which NaSH exerts anti-inflammatory effects in VILI.
Critically ill patients with acute lung injury are often
complicated with multiple sources of insult. However, it
is unclear whether the biological features of acute lung
injury are similar or not in response to different initial
insults. Lo´pez-Aguilar et al. [76] randomly divided rats
into three groups of acute lung injury models by using
either high tidal volume ventilation, massive brain injury
or endotoxin injection for 3 h. Despite the lack of evi-
dence of significant alternation in lung function and
structural changes, lung and systemic inflammatory
responses such as production of cytokines and extracel-
lular matrix proteins take place in all three models.
Furthermore, the early lung inflammatory responses are
similar in both direct and indirect lung injury models.
However, because the cytokines and extracellular matrix
proteins are not lung specific, it is difficult to separate the
possible systemic inflammatory effects from local effects
in the lung. Indeed, reliable biomarkers are very impor-
tant for clinicians in bedside management, both as a
diagnostic tool and as a follow-up of antibiotic therapy in
patients with sepsis. Long pentraxin-3 (PTX3) is a soluble
pathogen pattern recognition receptor for innate immu-
nity. Studies by He et al. [77] and by Mauri et al. [35]
were designed to test the validity of PTX3 as a biomarker
in a mouse model of endotoxemia and in patients with
sepsis. In the human study, the investigators reported that
the PTX3 levels remained elevated during the first 5 days
after the diagnosis of sepsis, and thus it appeared to be a
reliable prognostic marker; PTX3 levels had a better
discriminative power for survival than those of C reactive
protein, IL-6 and TNF-a. In the animal study, endotoxe-
mia was introduced by intratracheal instillation of LPS in
mice. After 24 h, PTX3 protein in the bronchoalveolar
lavage fluid was increased in parallel with the severity of
lung injury. Importantly, this study demonstrated that the
expression of PTX3 reflected an effective therapeutic
intervention following the use of tissue factor inhibitor,
which supports that PTX3 is a biomarker for acute lung
injury. Although the study results are exciting, the use of
PTX3 as a biomarker for heterogeneous and multi-organ
syndromes, such as sepsis and ARDS, is yet to be
established at bedside. An editorial by Zhang et al. [78]
accompanied the article. It is suggested that PTX3 should
be considered as a research tool in the field of intensive
care medicine.
A couple of studies examined the hypoperfusion status
and the effects of treatment in distal organ during
ischaemia/reperfusion. Acute renal failure is a frequent
complication contributing to high morbidity and mortality
in critically ill patients. Although the pathophysiology of
acute renal failure is not fully understood, there is general
agreement that renal hypoperfusion is an important factor
in the pathogenesis of acute renal failure. Saotome et al.
[79] conducted a study of a ewe model with various
degrees of renal hypoperfusion. They observed that 25, 50
or 75% impairment of renal blood flow for 30 min was
not associated with renal failure. During 2 h of 80%
hypoperfusion, renal dysfunction took place that was
reversed by restoration of normal renal blood flow. The
authors concluded that ‘‘unlike total ischemia, severe
hypoperfusion alone is insufficient to induce subsequent
persistent acute kidney injury’’. An excellent editorial by
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Drs. Groesdonk and Heringlake [80] accompanied the
article. They noted that this information is not really new,
but rarely recognized in the current literature. The edi-
torial further pointed out that the study did not determine
the humoral responses to renal hypoperfusion, but such
analyses may provide important insights into mechanisms
by which isolated renal low flow behaves differently from
the established models of combined systemic and renal
hypoperfusion. Another study focused on inflammatory
responses during ischaemia and reperfusion. In an intes-
tinal ischaemia/reperfusion injury model induced by
clamping both the superior mesenteric artery and the
celiac trunk in mice, Crisafulli et al. [81] observed that the
administration of olprinone, a specific phosphodiesterase-
III inhibitor, resulted in up-regulation of cAMP and
decreased injury in ileum tissue. The protective effects
were associated with decreased inflammatory responses,
suggesting an important signaling pathway during
ischaemia and reperfusion shock. These findings need to
be confirmed at multiple organs in different models for
future study.
Experimental models of infections and sepsis
Anthrax has received much attention in relation to its
possible use in bioterrorism. In a study published by Cui
et al. [82], the authors investigated the effects of cell walls
from Bacillus anthracis in comparison with those from
Staphylococcus aureus and bacterial endotoxin (LPS).
They showed that injection of high doses B. anthracis cell
walls to rats was lethal, and that lower doses induced a
marked inflammatory reaction, similar to that observed
with other types of bacterial agonists. Without finding a
clear explanation for this, they observed that non-lethal
injections of B. anthracis cell walls or LPS protected rats
again a subsequent infusion of the highly lethal B. an-
thracis toxin.
Newborns deprived of oxygen often develop pul-
monary hypertension and multiple organ dysfunction,
including cardiac failure. Joynt et al. [83] described a
hypoxia/reoxygenation neonatal swine model, and studied
the effects of epinephrine vs. dobutamine versus milri-
none in the resuscitation of the piglets. Whereas all drugs
improved cardiac output, only epinephrine and dobuta-
mine increased mean arterial pressure (MAP). Milrinone
just maintained MAP in comparison with control piglets
who underwent severe hypotension and shock. No sig-
nificant effect of the drugs was observed on the
pulmonary arterial pressures. Oxygen delivery was
increased in carotid and intestinal arteries with the three
drugs, whereas only milrinone seemed to increase renal
blood flow. The authors conclude that the three inotropes
improve cardiac output, and oxygen delivery to tissues,
with a small advantage in favour of milrinone owing to its
renal effect.
It has been proposed that mechanical ventilation per se
may influence innate immune defences of the lung. Villar
et al. [84] induced sepsis in rats by performing cecal
ligation and puncture, and randomized the rats to be
ventilated with high versus low levels of lung stretch, or
kept them spontaneously breathing. They found that a
protective ventilation strategy attenuated TLR4 activation
and decreased lung inflammation. In contrast, the injuri-
ous ventilation protocol increased lung TLR4 and IRAK3
levels, as well as lung and systemic inflammatory cyto-
kine levels. This study emphasizes the intimate
relationship between ventilation-induced lung inflamma-
tion and lung responses to bacterial agonists.
Renal impairment following colloid infusion has been
a concern in many animal and human studies. Schick
et al. [85] tested three fluid loading solutions in a model
of rats rendered septic by cecal ligation and puncture. All
the groups showed some alteration of renal function. The
less deleterious was a crystalloid isotonic balanced solu-
tion. Kidney from septic rats resuscitated with either
hydroxyethylstarch or gelatin showed marked impairment
of renal function and histologic renal tubular abnormali-
ties. This study adds to the concerns of using colloids as
fluid replacement therapy in sepsis.
Adrenal dysfunction is a hallmark of patients with
severe septic shock. However little is known about the
histological changes in adrenals from septic patients or
animals. Polito et al. [86] observed lipid depletion in the
zona fasciculata from adrenals obtained in patients who
died from septic shock. They observed similar abnor-
malities (as well as inflammation, necrosis and
haemorrhage) in adrenals from rodents rendered septic
with endotoxin or by cecal ligation and puncture. These
histological findings may explain the adrenal dysfunction
observed during severe sepsis syndromes.
Microvascular dysfunction with slower or stoppage of
blood flow in capillaries has been reported in many organs
in animal models of sepsis and in patients with septic
shock, and certainly participates in tissue hypoperfusion.
The intimate mechanisms of this capillary dysfunction
remain poorly understood in vivo. Using a fecal perito-
nitis model in mice, Secor et al. [87] investigated the role
of intravascular coagulation and platelet adhesion as a
possible mechanism for capillary obstruction. They found
that treatments with platelet depletion, P-selectin block-
ade (blockade of platelet adhesion), antithrombin, and
ascorbate as antioxidant prevented blood cells sludging in
microvessels. Studies with eNOS-deficient mice also
implicated NO in the prevention of the platelet aggrega-
tion and stoppage of blood in the microcirculation. This
study highlights the critical importance of platelet
aggregation in the microvasculature as a pathogenic role
for organ dysfunction during severe sepsis syndromes.
Both anti- and pro-inflammatory effects of b-agonists
have been reported. Tsao et al. [88] investigated the
effects of a b2-agonist, terbutaline, in a cecal ligation and
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puncture model in rats. They found that terbutaline pre-
vented systemic hypotension, reduced hepatic and renal
dysfunction, decreased plasma IL-1b, NO production and
tissue levels of reactive oxygen species, as well neutrophil
recruitment to the lung and liver. In addition, terbutaline
significantly improved survival rates in this rat model.
The authors postulate that the protective effect of ter-
butaline may be related to a decreased inflammation via
the activation of the b2 receptor.
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